Linde plc Earnings Recaps
Q2 2026
Aug 2, 2026
The stock declined 5.9% as investors reacted negatively to margin compression driven primarily by the underperforming U.S. homecare segment, overshadowing strong sales growth and backlog gains.
Key takeaways
- Sales grew 9% year-over-year to $9.3 billion, with underlying volume and price increases split evenly.
- Operating margins declined 30 basis points excluding cost pass-through effects, largely due to headwinds in the U.S. homecare business and higher low-margin equipment sales.
- The Americas segment was the main margin drag, with U.S. homecare portfolio struggles and the mix impact of hardgoods diluting margins.
- Backlog increased by $1 billion to a record $8.1 billion, fueled by electronics wins and ongoing project developments.
- EPS rose 10% to $4.50, supported by higher net income and a lower share count, but margin pressures raise concerns on near-term profitability.
Q1 2026
May 2, 2026
Linde’s first quarter results were met with a neutral market reaction, as shares closed up 1.4% after earnings. The quarter showed steady mid-single digit growth in several key end markets, though management flagged ongoing softness in European operations and continued cautiousness regarding impacts from geopolitical events.
Key takeaways
- Adjusted EPS rose 10% to $4.33, with operating margin reaching 30% and return on capital remaining at 24%.
- Total sales grew 8% year over year to $8.8 billion, though were flat sequentially.
- Healthcare end-market grew 1%, held back by flat U.S. home care volumes due to policy changes; food & beverage and electronics grew 5% and 10%, respectively, with electronics supported by AI chip-related demand.
- Industrial end market growth was led by the Americas; EMEA volumes remained pressured in chemicals, energy, and metals due to production shifting outside Continental Europe.
- Helium supply remains well managed despite global shortages, with Linde focused on contracted long-term business rather than spot sales for the remainder of the year.